Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Toheal Pharm
Toheal Pharm
BSE: 531910NSE: ISIN: INE312M01016

5th-Oct-2019 14:17Source: BSE

Toheal Pharma - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
1001
Name of the Signatory :- Manorama Shah
Designation :- Director

Board Meeting (Toheal Pharm)

Meeting Date

Remark

2019-11-14

Quarterly Results

Sections
Follow us on
Available On